MR in Drug Research Study Group
Tuesday, 21 May 2002
Room 315
19:30 - 21:30
Business Meeting | |
Scientific Meeting | |
How MRI Helps the Drug Industry
Discover and Develop More Valuable Medicines Faster John C. Waterton, Ph.D., AstraZeneca, Cheshire, England, UK |
|
What's Needed for DCEMRI in Trials
of Drugs Targeted at the Vasculature Martin O. Leach, Ph.D., Institute of Cancer Research, England, UK |
|
![]() |
Discussion Period |